EUROPE IMMUNOHISTOCHEMISTRY MARKET 2019-2027

MARKET OUTLOOK
The Europe immunohistochemistry market is projected to develop at a CAGR of 7.06% during the forecast period of 2019-2027.
Countries such as the United Kingdom, Germany, France, Italy, Spain, Russia as well as countries in rest of Europe have considered for this report.
The Germany immunohistochemistry market is mainly driven by the constant rise in the prevalence of CVDs in the country. According to the Organization for Economic Co-operation and Development (OECD), Germany has one of the highest death rates owing to heart disease in the OECD group of countries that is even higher than the United Kingdom and the United States. According to the Max Planck Institute for Biology and Aging, heart disorders are a major cause of death in the country. These heart disorders mainly include heart attacks, strokes and high blood pressure. There are various causes considering cardiovascular diseases that include genetics & natural aging and obesity & overweight, but smoking and high cholesterol can increase the risk on a large scale. Germany has a high prevalence of diabetes, which is also further augmenting the growth of the immunohistochemistry market in the country.
COMPETITIVE OUTLOOK
The companies leading the immunohistochemistry market are F. Hoffmann-La Roche AG, Abcam Plc, Agilent Technologies, Inc., Danaher Corporation, Histologix, Thermo Fisher Scientific, Inc., Cell Signaling Technology, Inc., Bio SB, Siemens AG Healthcare, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., BioGenex, Merck Millipore and Abbott Laboratories.

TABLE OF CONTENT
1. EUROPE IMMUNOHISTOCHEMISTRY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. HISTORY OF IMMUNOHISTOCHEMISTRY
2.3. VALUE CHAIN OUTLOOK
2.4. KEY INSIGHTS
2.5. MARKET ATTRACTIVENESS MATRIX
2.6. MARKET DRIVERS
2.6.1. IN-VITRO TECHNOLOGICAL ADVANCEMENTS
2.6.2. INCREASING OCCURRENCE OF CANCER
2.6.3. SWELLING HEALTHCARE SPENDING
2.6.4. INCREASING USE OF POC TESTING
2.7. MARKET RESTRAINTS
2.7.1. RESTRICTIONS OF CLOSED SYSTEMS
2.7.2. REIMBURSEMENT ISSUES
2.8. MARKET OPPORTUNITIES
2.8.1. INCREASING USE OF BIOMARKERS FOR DISEASE DIAGNOSIS
2.8.2. TECHNOLOGICAL ADVANCEMENTS
2.9. MARKET CHALLENGES
2.9.1. STRINGENT REGULATIONS
2.9.2. HIGH MAINTENANCE COST INFLUENCING THE MARKET GROWTH
3. IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY PRODUCTS
3.1. ANTIBODIES
3.1.1. PRIMARY ANTIBODIES
3.1.2. SECONDARY ANTIBODIES
3.2. EQUIPMENT
3.2.1. SLIDE STAINING SYSTEMS
3.2.2. TISSUE MICROARRAYS
3.2.3. TISSUE PROCESSING SYSTEMS
3.2.4. SLIDE SCANNERS
3.2.5. OTHER EQUIPMENT
3.3. REAGENTS
3.3.1. HISTOLOGICAL STAINS
3.3.2. BLOCKING SERA AND REAGENTS
3.3.3. CHROMOGENIC SUBSTRATES
3.3.4. FIXATION REAGENTS
3.3.5. STABILIZERS
3.3.6. ORGANIC SOLVENTS
3.3.7. PROTEOLYTIC ENZYMES
3.3.8. DILUENTS
3.4. KITS
4. IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY APPLICATIONS
4.1. DIAGNOSTICS
4.1.1. CANCER
4.1.2. INFECTIOUS DISEASES
4.1.3. CARDIOVASCULAR DISEASE
4.1.4. AUTOIMMUNE DISEASES
4.1.5. DIABETES MELLITUS
4.1.6. NEPHROLOGICAL DISEASES
4.2. DRUG TESTING
5. IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY END-USERS
5.1. HOSPITALS AND DIAGNOSTIC LABORATORIES
5.2. RESEARCH INSTITUTES
5.3. OTHER END-USERS
6. IMMUNOHISTOCHEMISTRY (IHC) MARKET - EUROPE
6.1. COUNTRY ANALYSIS
6.1.1. THE UNITED KINGDOM
6.1.2. FRANCE
6.1.3. GERMANY
6.1.4. SPAIN
6.1.5. ITALY
6.1.6. RUSSIA
6.1.7. REST OF EUROPE
7. COMPETITIVE LANDSCAPE
7.1. ABBOTT LABORATORIES
7.2. ABCAM PLC
7.3. AGILENT TECHNOLOGIES, INC.
7.4. BIOGENEX
7.5. BIO-RAD LABORATORIES, INC.
7.6. BIO SB
7.7. CELL SIGNALING TECHNOLOGY, INC.
7.8. DANAHER CORPORATION
7.9. F. HOFFMANN-LA ROCHE AG
7.10. HISTOLOGIX
7.11. MERCK MILLIPORE
7.12. PERKINELMER, INC.
7.13. SIEMENS AG HEALTHCARE
7.14. THERMO FISHER SCIENTIFIC, INC.
8. METHODOLOGY AND SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY





TABLE LIST
TABLE 1 EUROPE MARKET FOR IMMUNOHISTOCHEMISTRY 2019-2027 ($ MILLION)
TABLE 2 CANCER MARKERS USED IN DIAGNOSIS AND TREATMENT
TABLE 3 EUROPE IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 4 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES BY TYPE 2019-2026 ($ MILLION)
TABLE 5 CLINICALLY IMPORTANT MONOCLONAL ANTIBODIES
TABLE 6 SECONDARY ANTIBODY SELECTION
TABLE 7 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT BY TYPES 2019-2027 ($ MILLION)
TABLE 8 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS BY TYPE 2019-2027 ($ MILLION)
TABLE 9 HISTOLOGY STAINS AND ITS CATEGORIES
TABLE 10 COMMON FIXATIVES AND THEIR GENERAL TARGET ANTIGENS
TABLE 11 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN KITS 2019-2027 ($ MILLION)
TABLE 12 KIT COMPONENTS ARE AVAILABLE FOR IHC OPTIMIZATION
TABLE 13 EUROPE IMMUNOHISTOCHEMISTRY MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 14 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS BY TYPE 2019-2027 ($ MILLION)
TABLE 15 SELECTED INFECTIOUS ETIOLOGIES OF AUTOIMMUNE DISEASES
TABLE 16 EUROPE IMMUNOHISTOCHEMISTRY MARKET BY END-USERS 2019-2027 ($ MILLION)
TABLE 17 NUMBER OF PEOPLE LIVING AND DYING WITH CVD
TABLE 18 NUMBER OF DEATHS CAUSED BY CARDIOVASCULAR DISEASES IN GERMANY 2016
TABLE 19 DISEASES CAUSING PREMATURE DEATH IN GERMANY 2017





FIGURE LIST
FIGURE 1 EUROPE MARKET FOR IMMUNOHISTOCHEMISTRY 2019-2027 ($ MILLION)
FIGURE 2 HISTORY OF IMMUNOHISTOCHEMISTRY
FIGURE 3 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 4 EUROPE ANTIBODIES MARKET IN PRIMARY ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 5 EUROPE ANTIBODIES MARKET IN SECONDARY ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 6 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2019-2027 ($ MILLION)
FIGURE 7 EUROPE EQUIPMENT MARKET IN SLIDE STAINING SYSTEMS 2019-2027 ($ MILLION)
FIGURE 8 EUROPE EQUIPMENT MARKET IN TISSUE MICROARRAYS 2019-2027 ($ MILLION)
FIGURE 9 EUROPE EQUIPMENT MARKET IN TISSUE PROCESSING SYSTEMS 2019-2027 ($ MILLION)
FIGURE 10 EUROPE EQUIPMENT MARKET IN SLIDE SCANNERS 2019-2027 ($ MILLION)
FIGURE 11 EUROPE EQUIPMENT MARKET IN OTHER EQUIPMENT 2019-2027 ($ MILLION)
FIGURE 12 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2019-2027 ($ MILLION)
FIGURE 13 EUROPE REAGENTS MARKET IN HISTOLOGICAL STAINS 2019-2027 ($ MILLION)
FIGURE 14 EUROPE REAGENTS MARKET IN BLOCKING SERA AND REAGENTS 2019-2027 ($ MILLION)
FIGURE 15 EUROPE REAGENTS MARKET IN CHROMOGENIC SUBSTRATES 2019-2027 ($ MILLION)
FIGURE 16 EUROPE REAGENTS MARKET IN FIXATION REAGENTS 2019-2027 ($ MILLION)
FIGURE 17 EUROPE REAGENTS MARKET IN STABILIZERS 2019-2027 ($ MILLION)
FIGURE 18 EUROPE REAGENTS MARKET IN ORGANIC SOLVENTS 2019-2027 ($ MILLION)
FIGURE 19 EUROPE REAGENTS MARKET IN PROTEOLYTIC ENZYMES 2019-2027 ($ MILLION)
FIGURE 20 EUROPE REAGENTS MARKET IN DILUENTS 2019-2027 ($ MILLION)
FIGURE 21 PHASES OF HISTOLOGICAL STAINING
FIGURE 22 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN KITS 2019-2027 ($ MILLION)
FIGURE 23 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS 2019-2027 ($ MILLION)
FIGURE 24 EUROPE DIAGNOSTICS MARKET IN CANCER 2019-2027 ($ MILLION)
FIGURE 25 EUROPE DIAGNOSTICS MARKET IN INFECTIOUS DISEASES 2019-2027 ($ MILLION)
FIGURE 26 EUROPE DIAGNOSTICS MARKET IN CARDIOVASCULAR DISEASE 2019-2027 ($ MILLION)
FIGURE 27 EUROPE DIAGNOSTICS MARKET IN AUTOIMMUNE DISEASES 2019-2027 ($ MILLION)
FIGURE 28 EUROPE DIAGNOSTICS MARKET IN DIABETES MELLITUS 2019-2027 ($ MILLION)
FIGURE 29 EUROPE DIAGNOSTICS MARKET IN NEPHROLOGICAL DISEASES 2019-2027 ($ MILLION)
FIGURE 30 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2019-2027 ($ MILLION)
FIGURE 31 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2019-2027 ($ MILLION)
FIGURE 32 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2019-2027 ($ MILLION)
FIGURE 33 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN OTHER END-USERS 2019-2027 ($ MILLION)
FIGURE 34 THE UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 35 FRANCE IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 36 GERMANY IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 37 SPAIN IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 38 ITALY IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 39 RUSSIA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 40 REST OF EUROPE IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)